Markets

Insider Trading

Hedge Funds

Retirement

Opinion

ADMA Biologics, Inc. (ADMA): A Bull Case Theory

We came across a bullish thesis on ADMA Biologics, Inc. on Archive Invest’s Substack by Felix. In this article, we will summarize the bulls’ thesis on ADMA. ADMA Biologics, Inc.'s share was trading at $17.80 as of August 22nd. ADMA’s trailing and forward P/E were 20.94 and 28.99 respectively according to Yahoo Finance.

Adma Biologics (ADMA) has delivered a remarkable financial turnaround, with 2024 standing out as a pivotal year. Gross profit has compounded at an impressive 34% CAGR from 2020 to 2024, reflecting strong topline expansion. Net income has moved from a loss of $75.5...